215 related articles for article (PubMed ID: 29687475)
1. Diagnostic criteria, severity classification and guidelines of localized scleroderma.
Asano Y; Fujimoto M; Ishikawa O; Sato S; Jinnin M; Takehara K; Hasegawa M; Yamamoto T; Ihn H
J Dermatol; 2018 Jul; 45(7):755-780. PubMed ID: 29687475
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis.
Jinnin M; Yamamoto T; Asano Y; Ishikawa O; Sato S; Takehara K; Hasegawa M; Fujimoto M; Ihn H
J Dermatol; 2018 Aug; 45(8):881-890. PubMed ID: 29235676
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria, severity classification and guidelines of systemic sclerosis.
Asano Y; Jinnin M; Kawaguchi Y; Kuwana M; Goto D; Sato S; Takehara K; Hatano M; Fujimoto M; Mugii N; Ihn H
J Dermatol; 2018 Jun; 45(6):633-691. PubMed ID: 29687465
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus.
Hasegawa M; Ishikawa O; Asano Y; Sato S; Jinnin M; Takehara K; Fujimoto M; Yamamoto T; Ihn H
J Dermatol; 2018 Aug; 45(8):891-897. PubMed ID: 29265410
[TBL] [Abstract][Full Text] [Related]
5. German guidelines for the diagnosis and therapy of localized scleroderma.
Kreuter A; Krieg T; Worm M; Wenzel J; Moinzadeh P; Kuhn A; Aberer E; Scharffetter-Kochanek K; Horneff G; Reil E; Weberschock T; Hunzelmann N
J Dtsch Dermatol Ges; 2016 Feb; 14(2):199-216. PubMed ID: 26819124
[TBL] [Abstract][Full Text] [Related]
6. Localized scleroderma.
Kreuter A
Dermatol Ther; 2012; 25(2):135-47. PubMed ID: 22741933
[TBL] [Abstract][Full Text] [Related]
7. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
Knobler R; Moinzadeh P; Hunzelmann N; Kreuter A; Cozzio A; Mouthon L; Cutolo M; Rongioletti F; Denton CP; Rudnicka L; Frasin LA; Smith V; Gabrielli A; Aberer E; Bagot M; Bali G; Bouaziz J; Braae Olesen A; Foeldvari I; Frances C; Jalili A; Just U; Kähäri V; Kárpáti S; Kofoed K; Krasowska D; Olszewska M; Orteu C; Panelius J; Parodi A; Petit A; Quaglino P; Ranki A; Sanchez Schmidt JM; Seneschal J; Skrok A; Sticherling M; Sunderkötter C; Taieb A; Tanew A; Wolf P; Worm M; Wutte NJ; Krieg T
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1401-1424. PubMed ID: 28792092
[TBL] [Abstract][Full Text] [Related]
8. Morphea and localized scleroderma in children.
Vierra E; Cunningham BB
Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
[TBL] [Abstract][Full Text] [Related]
9. [AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma].
Kreuter A; Krieg T; Worm M; Wenzel J; Gambichler T; Kuhn A; Aberer E; Scharffetter-Kochanek K; Hunzelmann N;
J Dtsch Dermatol Ges; 2009 Sep; 7 Suppl 6():S1-14. PubMed ID: 19660073
[TBL] [Abstract][Full Text] [Related]
10. [How I explore ... the skin functional involvement in scleroderma].
Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
[TBL] [Abstract][Full Text] [Related]
11. Pediatric scleroderma: systemic or localized forms.
Torok KS
Pediatr Clin North Am; 2012 Apr; 59(2):381-405. PubMed ID: 22560576
[TBL] [Abstract][Full Text] [Related]
12. Update on management of scleroderma.
Sule SD; Wigley FM
Bull Rheum Dis; 2000; 49(10):1-4. PubMed ID: 11286150
[No Abstract] [Full Text] [Related]
13. Juvenile Scleroderma-What has Changed in the Meantime?
Adrovic A; Sahin S; Barut K; Kasapcopur O
Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
[TBL] [Abstract][Full Text] [Related]
14. A case of scleroderma associated with interstitial neutrophilic granulomatous reaction.
Sawamura S; Kajihara I; Ihn H
Australas J Dermatol; 2019 Nov; 60(4):e338-e340. PubMed ID: 31049924
[No Abstract] [Full Text] [Related]
15. [Diagnostic and therapeutic problems of scleroderma].
Pogorzelska-Antkowiak A; Antkowiak R
Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
[TBL] [Abstract][Full Text] [Related]
16. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
17. [Localized scleroderma (morphea) in childhood].
Weibel L
Hautarzt; 2012 Feb; 63(2):89-96. PubMed ID: 22290277
[TBL] [Abstract][Full Text] [Related]
18. Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF; Romiti R
An Bras Dermatol; 2015; 90(1):62-73. PubMed ID: 25672301
[TBL] [Abstract][Full Text] [Related]
19. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.
Knobler R; Geroldinger-Simić M; Kreuter A; Hunzelmann N; Moinzadeh P; Rongioletti F; Denton CP; Mouthon L; Cutolo M; Smith V; Gabrielli A; Bagot M; Olesen AB; Foeldvari I; Jalili A; Kähäri V; Kárpáti S; Kofoed K; Olszewska M; Panelius J; Quaglino P; Seneschal J; Sticherling M; Sunderkötter C; Tanew A; Wolf P; Worm M; Skrok A; Rudnicka L; Krieg T
J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):1251-1280. PubMed ID: 38456584
[TBL] [Abstract][Full Text] [Related]
20. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC
Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
